Lower incidence of nocturnal hypoglycaemia in patients with Type 2 diabetes treated with insulin glargine compared with NPH insulin, given as a combination regimen with oral agents.

被引：0
|
作者：
Benedetti, MM
Hamburg, E
Dressler, A
Ziemen, M
机构：
[1] Univ Perugia, I-06100 Perugia, Italy
[2] Aventis Pharma Deutschland GmbH, Frankfurt, Germany
来源：
DIABETOLOGIA | 2002年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
804
引用
收藏
页码：A259 / A259
页数：1
相关论文
共 50 条
  • [21] Hypoglycemia and postprandial glucose are lower with insulin glargine versus NPH insulin in older type 2 diabetes patients
    Fritsche, A
    Dailey, G
    Lin, Z
    Murray, F
    Häring, H
    Rosenstock, J
    [J]. GERONTOLOGIST, 2004, 44 : 221 - 221
  • [22] Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes
    Bolli, G. B.
    Songini, M.
    Trovati, M.
    Del Prato, S.
    Ghirlanda, G.
    Cordera, R.
    Trevisan, R.
    Riccardi, G.
    Noacco, C.
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2009, 19 (08) : 571 - 579
  • [23] Diabetic retinopathy in patients with type 1 diabetes treated with insulin glargine or NPH
    Peters, K
    Garg, SK
    JAckson, WE
    Mackenzie, T
    Queen, J
    Anil, S
    Chase, HP
    [J]. DIABETES, 2001, 50 : A443 - A443
  • [24] Reduced nocturnal hypoglycaemia with insulin degludec as compared to insulin glargine: results of a 2-year randomised trial in type 2 diabetes
    Rodbard, H. W.
    Zinman, B.
    Cariou, B.
    Philis-Tsimikas, A.
    Handelsman, Y.
    Skjoth, T. V.
    Chu, P. -L.
    Mathieu, C.
    [J]. DIABETOLOGIA, 2012, 55 : S378 - S378
  • [25] Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients
    Pan, Chang-Yu
    Sinnassamy, Patrick
    Chung, Kab-Do
    Kim, Kwang-Won
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (01) : 111 - 118
  • [26] Less symptomatic hypoglycemia with insulin glargine compared to NPH in patients with type 2 diabetes.
    Fonseca, V
    Bell, D
    Mecca, T
    [J]. DIABETOLOGIA, 2001, 44 : A207 - A207
  • [27] Insulin therapy in type 2 diabetes: A prospective 18 month comparison of insulin glargine and NPH insulin in patients with a multiple injection regimen
    Siegmund, T
    Born, T
    Weber, S
    Usadel, KH
    Schumm-Draeger, PM
    [J]. DIABETES, 2003, 52 : A456 - A456
  • [28] Economic analysis of insulin glargine compared with NPH insulin in the treatment of patients with Type 1 diabetes in Spain
    Terrés, CR
    Rodríguez, J
    Bolinder, B
    de Pablos, P
    [J]. DIABETOLOGIA, 2004, 47 : A345 - A345
  • [29] LOWER TREATMENT COSTS WITH INSULIN GLARGINE COMPARED TO INSULIN DETEMIR IN TYPE 1 DIABETES PATIENTS TREATED WITH A BASAL-BOLUS REGIMEN IN GERMANY
    Wiesner, T.
    Schaedlich, P. K.
    Dippel, F. W.
    Koltermann, K.
    Hagenmeyer, E. G.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A294 - A294
  • [30] Feasibility of improved glycemic control with insulin detemir and insulin glargine in combination with oral agents in insulin naive patients with type 2 diabetes
    Rosenstock, J
    Larsen, JJ
    Draeger, E
    Kristensen, HS
    Davies, M
    [J]. DIABETES, 2004, 53 : A145 - A145
12345